How to buy Ascendis Pharma A/S stock

Ascendis Pharma A/S is a biotechnology business based in the US. Ascendis Pharma A/S shares (ASND) are listed on the NASDAQ and all prices are listed in US Dollars. Ascendis Pharma A/S employs 330 staff and has a market cap (total outstanding shares value) of USD$8.2 billion.

How to buy shares in Ascendis Pharma A/S

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Ascendis Pharma A/S. Find the stock by name or ticker symbol: ASND. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Ascendis Pharma A/S reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Ascendis Pharma A/S, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Ascendis Pharma A/S. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Our top pick for

Beginners

Robinhood

Our top pick for

Building a portfolio

Sofi Invest

Our top pick for

Advanced traders

Interactive Brokers

How we chose our top picks

We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs. We encourage you to compare stock platforms to find one that's best for your particular budget and goals.

• Our pick for beginners. We chose Robinhood for this category because it offers commission-free trading and is easy to use. You can search for stocks by company name, and the mobile app is clean and intuitive to use.
• Our pick for building a portfolio. We chose SoFi for this category because it offers both commission-free stocks and a free robo-advisor. That means you can open an active investing account to pick and choose companies you want to invest in, and open a robo-advisor account to help you build a portfolio and manage how much risk you take on.
• Our pick for active traders. We picked Interactive Brokers for this category because it offers advanced tools and low fees for active investors and pros. The simpler IBKR Lite platform is aimed at less-active investors, but all users older than 21 must meet a $20,000 liquid net worth requirement for a cash account.

What's in this guide?

1. ASND shares summary
2. Compare share dealing platforms
3. Is ASND stock a buy or sell?
4. Stock performance over time
5. Can I short ASND shares?
6. Ascendis Pharma A/S's financials
7. How volatile are ASND shares?
8. Does Ascendis Pharma A/S pay a dividend?
9. Other common questions

Ascendis Pharma A/S share price

Use our graph to track the performance of ASND stocks over time.

Ascendis Pharma A/S shares at a glance

• Key figures

Information last updated 2021-02-23.

52-week range	USD$92 - USD$183.98
50-day moving average	USD$158.5229
200-day moving average	USD$157.794
Wall St. target price	USD$193.26
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-5.0945

Buy Ascendis Pharma A/S shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Sort by:

Name	Product	Stock trade fee	Asset types	Option trade fee	Annual fee	Signup bonus
Robinhood		$0	Stocks, Options, ETFs, Gold/Commodities	$0	0%	Free stock (chosen randomly with a value anywhere between $2.50 and $200) Sign up using the "go to site" link	Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.	Go to site More Info		loading Fetching your data...
Interactive Brokers		$0	Stocks, Bonds, Options	$0 + $0.65/contract, $1 minimum	0%	N/A	IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.	Go to site More Info		loading Fetching your data...
Tastyworks		$0	Stocks, Options, Cryptocurrency	Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg Futures: $2.50/contract to open, $0 to close	0%	Get 100 shares of stock (worth $1 to $6 a share) Open and fund a new cash or margin account with $2,000+	Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.	Go to site More Info		loading Fetching your data...
Moomoo		$0 for US stocks	Stocks, Options, ETFs	$0		N/A	Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.	Go to site More Info		loading Fetching your data...
TradeStation		$0	Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency	$0 + $0.50/contract		$50 Deposit qualifying assets of $5,000+	A platform built for all kinds of traders and all styles of trading	Go to site More Info		loading Fetching your data...

loading

Compare up to 4 providers

Clear selection

Compare

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Ascendis Pharma A/S stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Ascendis Pharma A/S by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Shorting Ascendis Pharma A/S shares

There are currently 2.1 million Ascendis Pharma A/S shares held short by investors – that's known as Ascendis Pharma A/S's "short interest". This figure is 1% down from 2.2 million last month.

There are a few different ways that this level of interest in shorting Ascendis Pharma A/S shares can be evaluated.

Ascendis Pharma A/S's "short interest ratio" (SIR)

Ascendis Pharma A/S's "short interest ratio" (SIR) is the quantity of Ascendis Pharma A/S shares currently shorted divided by the average quantity of Ascendis Pharma A/S shares traded daily (recently around 152554.2591267). Ascendis Pharma A/S's SIR currently stands at 13.97. In other words for every 100,000 Ascendis Pharma A/S shares traded daily on the market, roughly 13970 shares are currently held short.

However Ascendis Pharma A/S's short interest can also be evaluated against the total number of Ascendis Pharma A/S shares, or, against the total number of tradable Ascendis Pharma A/S shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ascendis Pharma A/S's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Ascendis Pharma A/S shares in existence, roughly 40 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Ascendis Pharma A/S shares, roughly 0 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Ascendis Pharma A/S.

Find out more about how you can short Ascendis Pharma A/S stock.

Ascendis Pharma A/S share price volatility

Over the last 12 months, Ascendis Pharma A/S's shares have ranged in value from as little as $92 up to $183.98. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ascendis Pharma A/S's is 0.7978. This would suggest that Ascendis Pharma A/S's shares are less volatile than average (for this exchange).

Ascendis Pharma A/S overview

Ascendis Pharma A/S, a biopharmaceutical company, develops various prodrug therapies for unmet medical needs. The company develops TransCon growth hormone, which has completed Phase III clinical study in children to treat growth hormone deficiency; TransCon parathyroid hormone which is in Phase II clinical study for treating hypoparathyroidism; and TransCon CNP, a long-acting prodrug of C-type natriuretic peptide which is in Phase II clinical for the treatment of achondroplasia. It is also developing preclinical studies in the field of oncology for potential product candidates and evaluate systemic and localized delivery systems using its TransCon technologies. It also has strategic collaborations with Sanofi to develop TransCon technologies for the treatment of diabetes. The company was founded in 2006 and is headquartered in Hellerup, Denmark.

Frequently asked questions

• What percentage of Ascendis Pharma A/S is owned by insiders or institutions?

  Currently 0.026% of Ascendis Pharma A/S shares are held by insiders and 101.599% by institutions.

• How many people work for Ascendis Pharma A/S?

  Latest data suggests 330 work at Ascendis Pharma A/S.

• When does the fiscal year end for Ascendis Pharma A/S?

  Ascendis Pharma A/S's fiscal year ends in December.

• Where is Ascendis Pharma A/S based?

  Ascendis Pharma A/S's address is: Tuborg Boulevard 12, Hellerup, Denmark, 2900

• What is Ascendis Pharma A/S's ISIN number?

  Ascendis Pharma A/S's international securities identification number is: US04351P1012

• What is Ascendis Pharma A/S's CUSIP number?

  Ascendis Pharma A/S's Committee on Uniform Securities Identification Procedures number is: 04351P101